Skip to main content

Table 1 Cohort characteristics

From: Use of erectile dysfunction treatments after prostate cancer treatment and their perceived impact on men’s sex life: an analysis of patient reported outcome survey data

Characteristics

n

%

Total number of men

5561

100

Age group

  

< 60yrs

894

16.1

60-69yrs

2457

44.2

70-79yrs

1954

35.1

80 + yrs

256

4.6

Primary treatment^

  

Prostatectomy

2,289

41.2

Radiation therapy

597

24.8

Radiation with ADT

327

5.8

Active Surveillance

909

16.4

Watchful waiting

58

1.0

ADT alone

143

2.6

Chemotherapy

3

0.05

No treatment recorded

1,245

22.4

Gleason score (total) at diagnosis

  

≤ 6

1,249

22.5

7

1,871

33.6

8–10

851

15.3

Missing

1,590

28.6

PSA at diagnosis

  

< 4 mg/mL

596

10.7

4– 10 mg/mL

3,165

56.9

> 10 mg/mL

1,327

23.9

Missing

473

8.5

Place of residence

  

Major City

4,650

83.6

Regional

667

12.0

Remote

244

4.4

Socio-Economic Index (Quintile)

  

Q1 (Most disadvantaged)

956

17.2

Q2

938

16.9

Q3

849

15.3

Q4

1,096

19.7

Q5 (Most advantaged)

1,705

30.7

Missing

17

0.2

Body Mass Index Category

  

Underweight - Healthy (< 18–24.99 kg/m2)

1,267

22.8

Overweight (25–29.9 kg/m2)

2,524

45.4

Obese (> 30 kg/m2)

1,499

26.9

Missing

271

4.9

Smoking status

  

Never smoked

2538

45.7

Past smoker

2597

46.7

Current smoker

385

6.9

Missing

41

0.7

PROMs timepoints (N = 10,387 surveys)

  

Baseline (pre-treatment)

2,855

27.5

3 months

1,436

13.8

6 months

1,621

15.6

12 months

2,428

23.4

2 years#

709

6.8

5 + years

1,338

12.9

Epic-26 sexual function domain score at:

median

IQR

Baseline

58.3

(25.0–83.3)

3 months

16.7

(8.3–34.0)

6 months

16.7

(8.3–36.2)

1 year

22.2

(10.0–57.0)

2 years

22.2

(12.5–57.0)

5 years

22.2

(12.5–54.2)

  1. ^ 26% of men on AS transitioned to either RP or XRT
  2. 9.3% of men having RP subsequently received ADT or XRT or both during follow-up
  3. Radiation therapy includes low dose rate brachy therapy (n = 89)
  4. Radiotherapy plus ADT include men on HDR brachy therapy (n = 68)
  5. # PROMs collection at 2-years post treatment ceased from January 2020